Hurley Capital »

Sionna Therapeutics shares owned by Hurley Capital

Quarter-by-quarter ownership of Sionna Therapeutics (SION) shares owned by Hurley Capital from 13F filings

Historical chart of Hurley Capital investment in Sionna Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sionna Therapeutics held by Hurley Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sionna Therapeutics by Hurley Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $5.0k 113 43.99

More positions owned by Hurley Capital

Enterprise Products Partners (EPD)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Scottsdale Fds Inter Term Treas (VGIT)
Vanguard Scottsdale Fds Vng Rus1000grw (VONG)
Sprott Asset Management Physical Silver (PSLV)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Blackrock Etf Trust Ii Isha Flex In Etf (BINC)
Alphabet Cap Stk Cl A (GOOGL)
Select Sector Spdr Tr St Str Techn Etf (XLK)
Morgan Stanley Com New (MS)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)

View all positions for Hurley Capital

Top funds holding Sionna Therapeutics

RA Capital Management
Tpg Gp A
Viking Global Investors
Atlas Venture Life Science Advisors
OrbiMed Advisors
Enavate Sciences GP
Adage Capital Partners GP
Jpmorgan Chase & Co
BlackRock
Jennison Associates
Citadel Advisors
Vanguard Capital Management
Perceptive Advisors
T. Rowe Price Associates
State Street Corporation

View all funds holding Sionna Therapeutics